期刊文献+

HPLC法测定卡巴拉汀贴剂中药物含量 被引量:1

HPLC method for the determination of drug in karbala patches statins content
下载PDF
导出
摘要 建立了关于卡巴拉汀贴片的含量的高效液相色谱(HPLC)测定方法,采用离体的豚鼠皮肤作为透皮屏障,运用改进的Franz扩散池,观察卡巴拉汀透皮贴剂的体外透皮效果。结果显示,在9.69 ̄116.32μg/mL的浓度范围中卡巴拉汀的线性关系良好,精密度RSD是0.12% ̄0.47%,检测限值是0.17pg/mL,低浓度的平均回收率为98.79%、中浓度为98.59%、高浓度为99.88%。实验中建立的HPLC方法具有准确、灵敏和操作简便的优点,对卡巴拉汀贴含量测定效果好。 set up about the content of the statins karbala patch high performance liquid chromatography (HPLC) method.using the improved Franz diffusion cell was observed in Kabbala,transdermal fentanyl transdermal effect. The results showed, in the concentration range of 9.69- 1 16.32u g/mL Kabbala ting good linearity, precision of RSD is 0.12% - 0.47%, limit of detection is0.17 pg/mL, low concentrations of the average recovery rate was 98.79%,in concentrations of 98.59%, high concentration of 99.88%. The proposed HPLC method is accurate,sensitive and the advantages of simple operation, the Kabbala Ting paste determination effect is good.
出处 《求医问药(下半月刊)》 2012年第7期403-404,共2页 Seek Medical and Ask The Medicine
关键词 HPLC 透皮贴剂 卡巴拉汀 HPLC Transdermal patches Karbala statins.
  • 相关文献

参考文献4

二级参考文献36

  • 1张丽萍,张洪娟,王朝宇.穴位透皮吸收制剂聚胺酯贴敷剂脑栓通的研制[J].黑龙江中医药,1996,25(6):46-46. 被引量:22
  • 2李娅芳,邓英杰,刘书琴,缪硕宁,韩丽梅,张寒煦.透皮吸收制剂研究进展[J].中国药学杂志,1997,32(1):3-7. 被引量:35
  • 3潘旭初.月桂氮怠酮对■丙嗪透皮吸收作用的研究[J].中国药学杂志,1997,32(1):25-27. 被引量:9
  • 4颜耀东,王勋章,黄晓洁,吴晓光.均匀设计法对中药贴敷剂基质配方的研究[J].中国药学杂志,1997,32(3):145-147. 被引量:7
  • 5[1]Meiran N, Stuss DT, Guzman DA, et al. Diagnosis of dementia:Methods for interpretation of scores of 5 neuropsychological test.Arch Neurol, 1996,53 (10): 1043.
  • 6[2]Rosler M, Anand R, Cicin - Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer' s disease: international randomized controlled trial. BMJ, 1999,318 (7184) :633.
  • 7[3]Risse SC, Raskind MA, Nochlin D,et al. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease. Am J Psychiatry,1990,147(2) :168.
  • 8[4]Shadlen MF, Larson EB. What' s new in Alzheimer' s disease treatment:Reasons for optimism about future pharmacologic options. Postgrad Med,1999,105(1): 109.
  • 9[5]Maire JC,Wurtman RJ. Choline production from choline -containing phospholipids: a hypothetical role in Alzheimer' s disease and aging. Prog Neuropsychopharmacol Biol Psychiatry, 1984,8(4 -6) :637.
  • 10[6]Guillozet AL, Mesulam MM, Mash DC, et al. Butyrylcholinesterase in the life cycle of amyloid plaques. Anu Neurol, 1997,42 (6):909.

共引文献15

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部